PADI4 and cancer: Pharmacological PAD-inhibition has shown promising results in cancer models both in vitro [45,46] and in vivo [43,47], as well as in animal models of various autoimmune diseases [48,49,50,51,52], neuronal injury [53], hypoxia [54], and atherosclerosis [55].